Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Siegfried Zaiss is active.

Publication


Featured researches published by Siegfried Zaiss.


European Journal of Pharmacology | 1990

Endothelin receptors in cultured renal epithelial cells

Dieter Neuser; Siegfried Zaiss; Johannes-Peter Stasch

We demonstrated the presence of specific binding sites for endothelin in the renal epithelial cell lines. MDCK and LLC-PK1. Endothelin binding induced mobilisation of intracellular calcium, as shown by an increase in 45Ca2+ efflux. This suggests a direct effect of endothelin on renal reabsorption in addition to the effects on the renal vasculature.


Archive | 1992

Substituted biphenylpyridinones as angiotensin II antagonists

Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Johannes-Peter Stasch; Andreas Dr. Knorr; Stefan Wohlfeil; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Siegfried Zaiss


Archive | 2000

New heterocyclic substituted pyridine derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis

Ulrich Dr Mueller; Gabriele Handke; Ruediger Fischer; Nicole Petesch; Carsten Schmeck; Axel Kretschmer; Ulrich Nielsch; Klaus-Dieter Bremm; Siegfried Zaiss


Archive | 1994

Substituted mono- and bipyridylmethylpyridones

Peter Fey; Walter Dr. Hübsch; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Hilmar Bischoff; Stefan Wohlfeil; Dirk Denzer; Stanislav Kazda; Johannes-Peter Stasch; Andreas Knorr; Siegfried Zaiss


Archive | 1991

Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation

Otto Behner; Hartmut Wollweber; Bruno Rosen; Siegfried Zaiss; Siegfried Goldmann


Archive | 1994

Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives

Ulrich E. Muller; Jürgen Dr. Dressel; Peter Fey; Rudolf H. Hanko; Walter Dr. Hübsch; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil; Andreas Knorr; Johannes-Peter Stasch; Siegfried Zaiss


Archive | 2001

Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL)

Rudi Grutzmann; Ulrich Dr. Müller; Hilmar Bischoff; Siegfried Zaiss


Chimia | 2004

Fluorine-substitution in cholesteryl ester transfer protein inhibitors (CETP-inhibitors): Biology, chemistry, SAR, and properties

Holger Paulsena; Carsten Schmeck; Arndt Brandes; Gunter Schmidt; Jurgen Stoltefuss; Stephan N. Wirtz; Michael Lögers; Paul Naab; Klaus-Dieter Bremm; Hilmar Bischoff; Delf Schmidt; Siegfried Zaiss; Stefan Antons


Archive | 1992

N-Alkylated 1,4-dihydropyridine carboxylicacid ester derivatives

Bruno Rosen; Siegfried Zaiss; Hartmund Wollweber; Hans-Georg Dr Dellweg; Jonge Maarten Dr. De


Archive | 2005

Substituted 1,2,4-triazin-5(2h)-ones

Martin Hendrix; Katja Zimmermann; Claudia Hirth-Dietrich; Gunter Karig; Dagmar Karthaus; Martin Raabe; Olaf Weber; Siegfried Zaiss

Collaboration


Dive into the Siegfried Zaiss's collaboration.

Researchain Logo
Decentralizing Knowledge